...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Phase 1B in TNBC suspended

"DMcC is busting at the seams with excitiment"

the way he's peeling money out of this this company to pay for his other job +'perks etc etc , I'd be excited too - it's never ending BS around these parts.

Share
New Message
Please login to post a reply